NCCN guidelines® insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines

Gregory P. Kalemkerian; Billy W. Loo; Wallace Akerley; Albert Attia; Michael Bassetti; Yanis Boumber; Roy Decker; M. Chris Dobelbower; Afshin Dowlati; Robert J. Downey; Charles Florsheim; Apar Kishor P. Ganti; John C. Grecula; Matthew A. Gubens; Christine L. Hann; James A. Hayman; Rebecca Suk Heist; Marianna Koczywas; Robert E. Merritt; Nisha Mohindra; Julian Molina; Cesar A. Moran; Daniel Morgensztern; Saraswati Pokharel; David C. Portnoy; Deborah Rhodes; Chad Rusthoven; Rafael Santana-Davila; Charles C. Williams; Karin G. Hoffmann; Miranda Hughes

doi:10.6004/jnccn.2018.0079

NCCN guidelines® insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines

Gregory P. Kalemkerian, Billy W. Loo, Wallace Akerley, Albert Attia, Michael Bassetti, Yanis Boumber, Roy Decker, M. Chris Dobelbower, Afshin Dowlati, Robert J. Downey, Charles Florsheim, Apar Kishor P. Ganti, John C. Grecula, Matthew A. Gubens, Christine L. Hann, James A. Hayman, Rebecca Suk Heist, Marianna Koczywas, Robert E. Merritt, Nisha MohindraJulian Molina, Cesar A. Moran, Daniel Morgensztern, Saraswati Pokharel, David C. Portnoy, Deborah Rhodes, Chad Rusthoven, Rafael Santana-Davila, Charles C. Williams, Karin G. Hoffmann, Miranda Hughes

Research output: Contribution to journal › Article › peer-review

76 Scopus citations

Abstract

The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy. For the 2018 update, new sections were added on "Signs and Symptoms of SCLC" and "Principles of Pathologic Review."

Original language	English (US)
Pages (from-to)	1171-1182
Number of pages	12
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	16
Issue number	10
DOIs	https://doi.org/10.6004/jnccn.2018.0079
State	Published - Oct 1 2018

ASJC Scopus subject areas

Oncology

Access to Document

10.6004/jnccn.2018.0079

Cite this

Kalemkerian, G. P., Loo, B. W., Akerley, W., Attia, A., Bassetti, M., Boumber, Y., Decker, R., Dobelbower, M. C., Dowlati, A., Downey, R. J., Florsheim, C., Ganti, A. K. P., Grecula, J. C., Gubens, M. A., Hann, C. L., Hayman, J. A., Heist, R. S., Koczywas, M., Merritt, R. E., ... Hughes, M. (2018). NCCN guidelines® insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 16(10), 1171-1182. https://doi.org/10.6004/jnccn.2018.0079

Kalemkerian, GP, Loo, BW, Akerley, W, Attia, A, Bassetti, M, Boumber, Y, Decker, R, Dobelbower, MC, Dowlati, A, Downey, RJ, Florsheim, C, Ganti, AKP, Grecula, JC, Gubens, MA, Hann, CL, Hayman, JA, Heist, RS, Koczywas, M, Merritt, RE, Mohindra, N, Molina, J, Moran, CA, Morgensztern, D, Pokharel, S, Portnoy, DC, Rhodes, D, Rusthoven, C, Santana-Davila, R, Williams, CC, Hoffmann, KG & Hughes, M 2018, 'NCCN guidelines® insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 16, no. 10, pp. 1171-1182. https://doi.org/10.6004/jnccn.2018.0079

@article{92abe05aa7244b72bbdb0246caf99486,

title = "NCCN guidelines{\textregistered} insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines",

abstract = "The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy. For the 2018 update, new sections were added on {"}Signs and Symptoms of SCLC{"} and {"}Principles of Pathologic Review.{"}",

author = "Kalemkerian, {Gregory P.} and Loo, {Billy W.} and Wallace Akerley and Albert Attia and Michael Bassetti and Yanis Boumber and Roy Decker and Dobelbower, {M. Chris} and Afshin Dowlati and Downey, {Robert J.} and Charles Florsheim and Ganti, {Apar Kishor P.} and Grecula, {John C.} and Gubens, {Matthew A.} and Hann, {Christine L.} and Hayman, {James A.} and Heist, {Rebecca Suk} and Marianna Koczywas and Merritt, {Robert E.} and Nisha Mohindra and Julian Molina and Moran, {Cesar A.} and Daniel Morgensztern and Saraswati Pokharel and Portnoy, {David C.} and Deborah Rhodes and Chad Rusthoven and Rafael Santana-Davila and Williams, {Charles C.} and Hoffmann, {Karin G.} and Miranda Hughes",

note = "Publisher Copyright: {\textcopyright} 2018 JNCCN - Journal of the National Comprehensive Cancer Network.",

year = "2018",

month = oct,

day = "1",

doi = "10.6004/jnccn.2018.0079",

language = "English (US)",

volume = "16",

pages = "1171--1182",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "10",

}

TY - JOUR

T1 - NCCN guidelines® insights

T2 - Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines

AU - Kalemkerian, Gregory P.

AU - Loo, Billy W.

AU - Akerley, Wallace

AU - Attia, Albert

AU - Bassetti, Michael

AU - Boumber, Yanis

AU - Decker, Roy

AU - Dobelbower, M. Chris

AU - Dowlati, Afshin

AU - Downey, Robert J.

AU - Florsheim, Charles

AU - Ganti, Apar Kishor P.

AU - Grecula, John C.

AU - Gubens, Matthew A.

AU - Hann, Christine L.

AU - Hayman, James A.

AU - Heist, Rebecca Suk

AU - Koczywas, Marianna

AU - Merritt, Robert E.

AU - Mohindra, Nisha

AU - Molina, Julian

AU - Moran, Cesar A.

AU - Morgensztern, Daniel

AU - Pokharel, Saraswati

AU - Portnoy, David C.

AU - Rhodes, Deborah

AU - Rusthoven, Chad

AU - Santana-Davila, Rafael

AU - Williams, Charles C.

AU - Hoffmann, Karin G.

AU - Hughes, Miranda

PY - 2018/10/1

Y1 - 2018/10/1

N2 - The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy. For the 2018 update, new sections were added on "Signs and Symptoms of SCLC" and "Principles of Pathologic Review."

AB - The NCCN Guidelines for Small Cell Lung Cancer (SCLC) address all aspects of disease management. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for SCLC regarding immunotherapy, systemic therapy, and radiation therapy. For the 2018 update, new sections were added on "Signs and Symptoms of SCLC" and "Principles of Pathologic Review."

UR - http://www.scopus.com/inward/record.url?scp=85054896528&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054896528&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2018.0079

DO - 10.6004/jnccn.2018.0079

M3 - Article

C2 - 30323087

AN - SCOPUS:85054896528

SN - 1540-1405

VL - 16

SP - 1171

EP - 1182

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 10

ER -

NCCN guidelines® insights: Small cell lung cancer, version 2.2018 featured updates to the NCCN guidelines

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this